DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie


Sledge jr GW, Toi M, Neven P. et al
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial.

JAMA Oncol 2019;
DOI: 10.1001/jamaoncol. 2019.4782.

Download Bibliographical Data

Search in: